2022
Corticosteroid-Induced Glaucoma
Liu J, Arrigg C. Corticosteroid-Induced Glaucoma. 2022, 2541-2560. DOI: 10.1007/978-3-030-42634-7_183.Peer-Reviewed Original ResearchPrimary open-angle glaucomaCorticosteroid-induced glaucomaOpen-angle glaucomaCorticosteroid useOcular hypertensionAngle glaucomaCorticosteroid-induced ocular hypertensionIntraocular pressure elevationEffect of corticosteroidsRoute of administrationSecondary glaucomaClinical coursePressure elevationSystemic disordersRisk factorsFamily historyEffective treatmentOutflow facilityGlaucomaOcular tissuesTrabecular meshworkCareful monitoringIntracellular alterationsHypertensionCorticosteroids
2020
Corticosteroid-Induced Glaucoma
Liu J, Arrigg C. Corticosteroid-Induced Glaucoma. 2020, 1-20. DOI: 10.1007/978-3-319-90495-5_183-1.ChaptersPrimary open-angle glaucomaCorticosteroid-induced glaucomaOpen-angle glaucomaCorticosteroid useOcular hypertensionAngle glaucomaCorticosteroid-induced ocular hypertensionIntraocular pressure elevationEffect of corticosteroidsRoute of administrationSecondary glaucomaClinical coursePressure elevationSystemic disordersRisk factorsFamily historyEffective treatmentOutflow facilityGlaucomaOcular tissuesTrabecular meshworkCareful monitoringIntracellular alterationsHypertensionCorticosteroids
2017
Epigenetics and Signaling Pathways in Glaucoma
Gauthier AC, Liu J. Epigenetics and Signaling Pathways in Glaucoma. BioMed Research International 2017, 2017: 5712341. PMID: 28210622, PMCID: PMC5292191, DOI: 10.1155/2017/5712341.Peer-Reviewed Original ResearchConceptsPotential new therapeutic targetGeneration of fibrosisNovel therapeutic agentsNew therapeutic targetsAqueous humor drainageProapoptotic gene expressionRetinal neuronsIrreversible blindnessCommon causeHuman trialsTherapeutic targetAnimal modelsTrabecular meshworkTherapeutic agentsNeurodegenerative diseasesProsurvival factorBcl-2Rho-kinaseGlaucomaSignaling pathwaysPathway membersMAP kinaseGene expressionPathwayPreliminary success